☆ 4.6 Article

A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Review Cell Biology

An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation

Tristram A. J. Ryan et al.

Summary: Microbial detection by innate immune cells induces the expression of type I interferons (IFNs), which play a crucial role in coordinating innate immune responses. However, type I IFNs also interact with coagulation-related factors and modulate vascular function and thrombosis. This interaction may contribute to the increased risk of thrombotic complications in infection and type I interferonopathies. Pharmacological regulation of type I IFN signalling could be a potential therapeutic approach for treating aberrant coagulation and thrombosis.

CELLS (2023)

Add to Collection

Article Medicine, General & Internal

Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021

Isaac See et al.

Summary: This study describes the surveillance data and reporting rates of TTS cases after COVID-19 vaccination in the United States. TTS cases were more common and had higher reporting rates after Ad26.COV2.S vaccination, with most cases requiring hospitalization. There were only a few reported cases and a lower reporting rate of TTS after mRNA-based COVID-19 vaccines.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection

Article Clinical Neurology

Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination

Mathias Fousse et al.

Summary: This report presents cases of two young female patients who developed cerebral sinus vein thrombosis after receiving the ChAdOx1 vaccine. Both patients had specific physiological characteristics and genetic mutations. A notable finding was the development of immunity against SARS-CoV-2 following vaccination.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Letter Hematology

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT

Adam J. Kanack et al.

BLOOD (2022)

Add to Collection

Article Hematology

Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study

Elena Campello et al.

Summary: This study longitudinally evaluated coagulation profiles in healthy subjects who received COVID-19 vaccination and found that although there was a slight increase in thrombin generation in some subjects after vaccination, there was no clinically significant hypercoagulability. Platelet count, aggregation, and thromboelastometry parameters did not show relevant differences. No thrombotic or hemorrhagic events occurred.

THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Immunology

Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination

Alessandra Buoninfante et al.

Summary: This article summarizes the discussion of an EMA workshop on the epidemiology, clinical presentation, and biology of thrombosis with thrombocytopenia syndrome after adenovirus vector COVID-19 vaccination. International regulators, scientists, and developers have reached a general agreement on the steps needed to improve the understanding of this new syndrome, including enhancing post-vaccination surveillance activities in low and middle income countries and investigating potential genetic predisposition factors.

NPJ VACCINES (2022)

Add to Collection

Article Immunology

Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil

Patricia Mouta Nunes de Oliveira et al.

Summary: This case series study describes vaccine-induced immune thrombotic thrombocytopenia (VITT) cases following COVID-19 vaccination in Brazil, including ChAdOx1 nCoV-19, Ad26.COV2.S, and BNT162b2 vaccines, and describes their clinical and laboratory characteristics. The study findings suggest that VITT is a very rare but serious adverse event following COVID-19 immunization.

VACCINE (2022)

Add to Collection

Article Hematology

A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing

Thomas G. Deloughery et al.

Summary: Testing for polymorphisms in the MTHFR gene is not necessary for thrombophilia testing, as it has been found to have no correlation with arterial or venous thrombosis. Eliminating MTHFR testing will reduce patient concerns and healthcare costs.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Immunology

Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil

Patricia Mouta Nunes de Oliveira et al.

Summary: This case series study described the clinical and laboratory characteristics of VITT cases following COVID-19 vaccination in Brazil. Most cases occurred in women with central nervous system as the main site of thrombosis, and the median onset of symptoms was 8 days post-vaccination.

VACCINE (2022)

Add to Collection

Article Hematology

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia

Andreas Greinacher et al.

Summary: The mechanism underlying vaccine-induced immune thrombotic thrombocytopenia (VITT) primarily involves the formation of PF4/vaccine complexes and the proinflammatory environment stimulated by the vaccine, leading to the production of high-titer anti-PF4 antibodies in the body and consequent thrombosis.

BLOOD (2021)

Add to Collection

Article Hematology

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination

Stefan Handtke et al.

Summary: Vaccination plays a crucial role in combating the pandemic caused by the SARS-CoV-2 virus. The rare complication of thrombocytopenia and thrombotic complications after ChAdOx1 nCov-19 vaccination can be identified using a widely applicable whole-blood standard flow cytometric assay, allowing for rapid diagnosis by many laboratories.

BLOOD (2021)

Add to Collection

Article Medicine, General & Internal

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Nina H. Schultz et al.

Summary: This study reports five cases of venous thrombosis and thrombocytopenia occurring 7 to 10 days after receiving the ChAdOx1 nCoV-19 vaccine, suggesting a rare vaccine-induced immune thrombotic thrombocytopenia. The condition, which can lead to catastrophic outcomes such as cerebral venous sinus thrombosis, may be treated with intravenous immune globulin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Hematology

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know

Gowthami M. Arepally et al.

BLOOD (2021)

Add to Collection

Article Medicine, General & Internal

Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis

Sue Pavord et al.

Summary: Phenotypes of VITT were defined in 220 patients in the United Kingdom who presented a median of 14 days after the first ChAdOx1 nCoV-19 vaccination. Half had cerebral venous sinus thrombosis, a third of whom also had intracranial hemorrhage. Mortality was 22%. Intravenous immune globulin may reverse VITT.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Critical Care Medicine

Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19

Gian Paolo Castelli et al.

CRITICAL CARE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: A meta-analysis of 99 genetic association studies

Juan Zeng et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)

Add to Collection

Article Obstetrics & Gynecology

Factor 11 single-nucleotide variants in women with heavy menstrual bleeding

Sophie Wiewel-Verschueren et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis

Laura Martin-Fernandez et al.

PLOS ONE (2017)

Add to Collection

Article Hematology

Association between rs1801133 polymorphismand risk of adult ischemic stroke: Meta-analysis based on case-control studies

Min Chen et al.

THROMBOSIS RESEARCH (2016)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation

Gianluca Campo et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)

Add to Collection

Article Genetics & Heredity

ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing

Scott E. Hickey et al.

GENETICS IN MEDICINE (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.